insights_auto
Why is ORX down 2,59%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,35 SEK
arrow_downward
-2,59%(-0,036) 1D
6 қар., 12:53:08 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,47 SEK
High
1,47 SEK
Low
1,32 SEK
Mkt. cap
47,50 млн
Avg. vol.
320,60 м.
Volume
335,54 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,47 SEK
High
1,47 SEK
Low
1,32 SEK
Mkt. cap
47,50 млн
Avg. vol.
320,60 м.
Volume
335,54 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
19 минут бұрын
Asia’s Chip Stocks Crashed Overnight, With SK Hynix Down 11.7% And Taiwan Off More Than 8%. Now Nasdaq Futures Are Pointing Higher
Business of Cannabis
·
46 минут бұрын
Brains Bioceutical To List On NASDAQ Via SPAC At US$750m Valuation
CNBC
·
18 минут бұрын
Nasdaq futures make a small comeback after the tech wreck sends it into correction territory
Reuters
·
1 сағат бұрын
Nasdaq futures rise after steep AI selloff as chip stocks stabilize
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com